To actively target and enhance cellular uptake in mammary cancer cells, the nanoparticle surface was functionalized with a human epidermal growth factor receptor 2 (HER2)-specific Affibody and/or the cell-penetrating peptide TAT using the SpyTag–SpyCatcher ligation system. The gene discussed is ERBB2; the disease is breast cancer.